Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have different hormone levels than those without it.

Women with PCOS have shorter reproductive periods and higher infertility rates compared to healthy women.

Finasteride helps induce ovulation in nonresponder PCOS women.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Age is more important than BMI for IVF success in women with infertility and PCOS.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

Medroxyprogesterone acetate is as effective as oral contraceptives for resuming ovulation in women with PCOS.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Laparoscopic ovarian drilling improves menstrual cycles, hormone levels, and pregnancy rates in women with PCOS.

Women with PCOS have different hormone levels compared to those without PCOS.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Women with PCOS have higher levels of certain hormones compared to healthy women, and these levels vary with BMI, age, and treatment type.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Neurosteroids help regulate oxytocin levels, especially during stress and pregnancy, to protect against premature labor.

Oligomenorrhea is the strongest predictor of PCOS severity.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Transvaginal hydrolaparoscopy is effective for increasing ovulation and pregnancy rates in women with PCOS who didn't respond to clomiphene.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Obesity greatly affects polycystic ovarian syndrome, and losing weight should be the first treatment for obese patients to improve their chances of ovulation and pregnancy.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Letrozole combined with Cabergoline improves ovulation and pregnancy rates in women with PCOS and high prolactin levels compared to Letrozole alone.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.